Anjarium Biosciences
Last updated: September 06, 2025
Founder Joël de Beer
Country: Switzerland | Funding: $61M (+) | Add Funding
Website: https://www.anjarium.com/
Pioneering the next generation of non-viral gene therapy. Viral vectors have enabled early successes in the gene therapy space, but their immunogenicity, limited payload capacity and complex manufacturing are headwinds for the field. Anjarium is squarely focused on those challenges.
Website: https://www.anjarium.com/
Pioneering the next generation of non-viral gene therapy. Viral vectors have enabled early successes in the gene therapy space, but their immunogenicity, limited payload capacity and complex manufacturing are headwinds for the field. Anjarium is squarely focused on those challenges.
